Stock CLDX CELLDEX THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Relative Strength Chart Celldex Therapeutics, Inc.

Equities

CLDX

US15117B2025

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-21 pm EDT 		5-day change 1st Jan Change
37.67 USD -0.21% Intraday chart for Celldex Therapeutics, Inc. -4.56% -5.02%
May. 15 Celldex Therapeutics Reports First Patient Dosed in Phase 2 Skin Disorder Study MT
May. 15 Celldex Therapeutics, Inc. Announces First Patient Dosed in Phase 2 Study of Barzolvolimab in Prurigo Nodularis CI

End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
CELLDEX THERAPEUTICS, INC.
Other Biotechnology & Medical Research
-0.21%-4.56%-5.02%+14.53%+1,062.65% 2.49B
Neutral
Bullish
Bullish
  1. Stock Market
  2. Equities
  3. CLDX Stock
  4. Charts Celldex Therapeutics, Inc.
  5. Relative Strength Chart
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW